ALACHUA, Fla., Sept. 18 /PRNewswire-FirstCall/ -- Oragenics, Inc. (Amex: ONI - News) announced that its scientists, in collaboration with research groups from Utrecht University and the University of Groningen, both in the Netherlands, and led by Dr. Eefjan Breukink, have identified a novel mechanism for killing bacteria by its lead antibiotic candidate, MU1140(TM). Following review by outside experts, the results of this study are reported in this week's issue of Science, one of the world's most prestigious scientific journals.
